Progression of portal hypertension after atezolizumab plus bevacizumab for hepatocellular carcinoma-report a case and literature review

Background: Atezolizumab/bevacizumab combination therapy became the first-line therapy for advanced hepatocellular carcinoma (HCC). Gastroesophageal varices should be monitored and managed before treatment. The progression of portal hypertension during bevacizumab-containing therapy is unclear. Meth...

Full description

Bibliographic Details

Published in:	Journal of the Formosan Medical Association
Main Authors:	Tung-Yen Lin, Tung-Hung Su
Format:	Article
Language:	English
Published:	Elsevier 2024-08-01
Subjects:	Liver cancer Immunotherapy VEGF Varices Ascites Hepatic hydrothorax
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664624001803